Acropolis Investment Management LLC Sells 315 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Acropolis Investment Management LLC reduced its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,528 shares of the financial services provider’s stock after selling 315 shares during the period. Acropolis Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $995,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. PVG Asset Management Corp bought a new position in shares of iShares Biotechnology ETF in the second quarter valued at $415,000. Huntington National Bank raised its holdings in shares of iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after acquiring an additional 160 shares during the last quarter. National Bank of Canada FI lifted its position in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after acquiring an additional 229 shares in the last quarter. First Financial Bank Trust Division purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $204,000. Finally, Thrive Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter worth $445,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.8 %

Shares of IBB stock opened at $131.57 on Wednesday. The firm has a 50-day moving average of $137.51 and a 200-day moving average of $141.93. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.